• About us
  • Team
  • Privacy Policy
  • Contact
Saturday, November 21, 2026
  • Login
No Result
View All Result
World's first weekly chronicle of development news
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
No Result
View All Result
World's first weekly chronicle of development news
No Result
View All Result

Gene-based blood test may help predict early signs of cancer’s return

by Blitz India Media
April 16, 2025
in News
0
blood
Blitz Bureau

NEW DELHI: Monitoring blood levels of DNA fragments shed by dying tumour cells may accurately predict cancer recurrence, according to a new study. Researchers at New York University-Langone Health, US, focussed on nearly 600 men and women from Europe, North America, and Australia, with stage III melanoma — among the most aggressive forms of skin cancer.

The study showed that approximately 80 per cent of skin cancer patients with detectable levels of circulating tumour DNA (ctDNA), before they started treatment to suppress their tumours, went on to experience recurrence.
The disease was also found to return more than four times faster in this group than in those with no detectable levels of the biomarker, and the higher their levels, the faster the cancer returned.

“Our findings suggest that circulating tumour DNA tests could help oncologists identify which melanoma patients are most likely to respond well to therapy,” said study lead author Mahrukh Syeda, a research scientist at NYU Grossman School of Medicine.

“In the future, such assessments may be used routinely in the clinic to help guide treatment decisions,” added Syeda.

In the study, published in the journal The Lancet Oncology, the team also found that nearly all of those with detectable levels of ctDNA at three, six, nine, or 12 months into treatment experienced melanoma recurrence.
As a result, the researchers said, if the gene fragments are not observable prior to therapy but appear later on, this could indicate that the disease might be worsening.

Syeda said that the ctDNA method works by focusing on the most common mutations in the genetic code in melanoma cells. The mutated DNA spills into surrounding blood as the cells break down.

Further, the team showed that assessing ctDNA levels were as good or better at predicting recurrence than other experimental tests that examine a tumour itself, such as those that measure immune activity within a group of cancer cells.

Related Posts

India and France Strengthen Counter-Terrorism Cooperation
News

India, France discuss ways to counter terror financing

November 20, 2026
Indian stock market
News

Sensex jumps 898 points, Nifty closes above 25,800

November 20, 2026
Jaiswal
News

Jaiswal’s 85, Rahul’s unbeaten fifty puts India in charge against New Zealand

November 20, 2026
EPFO
News

EPFO approves monthly pension-style withdrawl from PF corpus

November 20, 2026
India-Japan Defence Cooperation
News

India, Japan reaffirm commitment to free, open and rules-based Indo-Pacific

November 19, 2026
Indian stock market
News

Sensex jumps 990 points, Nifty reclaims 25,500 as auto stocks power rally

November 19, 2026
Load More
Next Post
Industry Minister Piyush Goyal

India to become trusted bridge of global connectivity through IMEC: Goyal

Recent News

India and France Strengthen Counter-Terrorism Cooperation
News

India, France discuss ways to counter terror financing

by Blitz India Media
November 20, 2026
0

Blitz Bureau New Delhi, 20 November: India and France held the 18th meeting of the Joint Working Group (JWG) on...

Read moreDetails
Indian stock market

Sensex jumps 898 points, Nifty closes above 25,800

November 20, 2026
Jaiswal

Jaiswal’s 85, Rahul’s unbeaten fifty puts India in charge against New Zealand

November 20, 2026
EPFO

EPFO approves monthly pension-style withdrawl from PF corpus

November 20, 2026
India-Japan Defence Cooperation

India, Japan reaffirm commitment to free, open and rules-based Indo-Pacific

November 19, 2026

Blitz Highlights

  • Special
  • Spotlight
  • Insight
  • Entertainment
  • Health

International Editions

  • US (New York)
  • UK (London)
  • Middle East (Dubai)
  • Tanzania (Africa)

Nation

  • East
  • West
  • South
  • North
  • Hindi Edition

E-paper

  • India
  • Hindi E-paper
  • Dubai E-Paper
  • USA E-Paper
  • UK-Epaper
  • Tanzania E-paper

Useful Links

  • About us
  • Team
  • Privacy Policy
  • Contact

©2024 Blitz India Media -Building A New Nation

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

    No Result
    View All Result
    • Blitz Highlights
      • Special
      • Spotlight
      • Insight
      • Entertainment
      • Sports
    • Opinion
    • Legal
    • Perspective
    • Nation
      • East
      • West
      • North
      • South
    • Business & Economy
    • World
    • Hindi Edition
    • International Editions
      • Dubai
      • Tanzania
      • United Kingdom
      • USA
    • Blitz India Business

    ©2024 Blitz India Media -Building A New Nation